Introduction Women living with HIV experience heightened risk of cervical cancer, and over
50% of cases in Southern Africa are attributed to HIV co-infection. Cervical cancer …

Background: In settings with high HIV prevalence, cervical cancer incidence rates are up to
six-fold higher than the global average of 13.1/100,000 women-years. To achieve global …

The WHO strategy for the elimination of cervical cancer sets 2030 targets for the scale-up of
HPV vaccination, cervical screening, and pre-cancer and invasive cancer treatment …

Summary Background In 2020, the World Health Organization (WHO) launched its initiative
to eliminate cervical cancer as a public health problem. To inform global efforts for countries …

Introduction In settings with high HIV prevalence, cervical cancer incidence rates are up to
six‐fold higher than the global average of 13.1 cases per 100,000 women‐years. To inform …

Objectives Mathematical modeling is increasingly used to inform cervical cancer control
policies, and model-based evaluations of such policies in women living with human …

Background Women with HIV have an elevated risk of HPV infection, and eventually,
cervical cancer. Tanzania has a high burden of both HIV and cervical cancer, with an HIV …

Introduction: Women living with human immunodeficiency virus (WLHIV) face elevated risks
of human papillomavirus (HPV) acquisition and cervical cancer (CC). Coverage of CC …

HIV substantially worsens human papillomavirus (HPV) carcinogenicity and contributes to
an important population excess of cervical cancer, particularly in sub‐Saharan Africa (SSA) …

Previous studies reported human immunodeficiency virus (HIV) could enhance human
papillomavirus (HPV)‐induced cervical cancer. Therefore, the burden of cervical cancer …